Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David G Warnock

Showing results (171-180 of 209) with videos related to

Pageof 21
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 28, 2017
Serum albumin concentration and risk of end-stage renal disease: the REGARDS studyCarl P Walther, Orlando M Gutiérrez, Mary Cushman, et al.
American Journal of Nephrology|June 7, 2014
Mechanisms contributing to adverse cardiovascular events in patients with type 2 diabetes mellitus and stage 4 chronic kidney disease treated with bardoxolone methylMelanie P Chin, Scott A Reisman, George L Bakris, et al.
The New England Journal of Medicine|June 25, 2011
Bardoxolone methyl and kidney function in CKD with type 2 diabetesPablo E Pergola, Philip Raskin, Robert D Toto, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 16, 2015
A Meta-analysis of the Association of Estimated GFR, Albuminuria, Diabetes Mellitus, and Hypertension With Acute Kidney InjuryMatthew T James, Morgan E Grams, Mark Woodward, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 9, 2023
Risk Factors for Incident CKD in Black and White Americans: The REGARDS StudyKatharine L Cheung, Deidra C Crews, Mary Cushman, et al.
Kidney International|October 1, 2015
Deletion of mineralocorticoid receptors in smooth muscle cells blunts renal vascular resistance following acute cyclosporine administrationCristian A Amador, Jean-Philippe Bertocchio, Gwennan Andre-Gregoire, et al.
The American Journal of the Medical Sciences|January 19, 2013
Low hemoglobin levels and recurrent falls in U.S. men and women: prospective findings from the REasons for Geographic And Racial Differences in Stroke (REGARDS) cohortC Barrett Bowling, Paul Muntner, Brian D Bradbury, et al.
Kidney International|December 11, 2002
Sodium ferric gluconate complex in hemodialysis patients. II. Adverse reactions in iron dextran-sensitive and dextran-tolerant patientsDaniel W Coyne, N Franklin Adkinson, Allen R Nissenson, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|August 3, 2013
Acute hyperkalemia associated with inhalation of a potent ENaC antagonist: Phase 1 trial of GS-9411Thomas G O'Riordan, Karl H Donn, Peter Hodsman, et al.
American Journal of Nephrology|February 7, 2018
Bardoxolone Methyl Improves Kidney Function in Patients with Chronic Kidney Disease Stage 4 and Type 2 Diabetes: Post-Hoc Analyses from Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes StudyMelanie P Chin, George L Bakris, Geoffrey A Block, et al.
Pageof 21

Showing results (171-180 of 209) with videos related to

Sort By:
Pageof 21
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 28, 2017
Serum albumin concentration and risk of end-stage renal disease: the REGARDS studyCarl P Walther, Orlando M Gutiérrez, Mary Cushman, et al.
American Journal of Nephrology|June 7, 2014
Mechanisms contributing to adverse cardiovascular events in patients with type 2 diabetes mellitus and stage 4 chronic kidney disease treated with bardoxolone methylMelanie P Chin, Scott A Reisman, George L Bakris, et al.
The New England Journal of Medicine|June 25, 2011
Bardoxolone methyl and kidney function in CKD with type 2 diabetesPablo E Pergola, Philip Raskin, Robert D Toto, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 16, 2015
A Meta-analysis of the Association of Estimated GFR, Albuminuria, Diabetes Mellitus, and Hypertension With Acute Kidney InjuryMatthew T James, Morgan E Grams, Mark Woodward, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 9, 2023
Risk Factors for Incident CKD in Black and White Americans: The REGARDS StudyKatharine L Cheung, Deidra C Crews, Mary Cushman, et al.
Kidney International|October 1, 2015
Deletion of mineralocorticoid receptors in smooth muscle cells blunts renal vascular resistance following acute cyclosporine administrationCristian A Amador, Jean-Philippe Bertocchio, Gwennan Andre-Gregoire, et al.
The American Journal of the Medical Sciences|January 19, 2013
Low hemoglobin levels and recurrent falls in U.S. men and women: prospective findings from the REasons for Geographic And Racial Differences in Stroke (REGARDS) cohortC Barrett Bowling, Paul Muntner, Brian D Bradbury, et al.
Kidney International|December 11, 2002
Sodium ferric gluconate complex in hemodialysis patients. II. Adverse reactions in iron dextran-sensitive and dextran-tolerant patientsDaniel W Coyne, N Franklin Adkinson, Allen R Nissenson, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|August 3, 2013
Acute hyperkalemia associated with inhalation of a potent ENaC antagonist: Phase 1 trial of GS-9411Thomas G O'Riordan, Karl H Donn, Peter Hodsman, et al.
American Journal of Nephrology|February 7, 2018
Bardoxolone Methyl Improves Kidney Function in Patients with Chronic Kidney Disease Stage 4 and Type 2 Diabetes: Post-Hoc Analyses from Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes StudyMelanie P Chin, George L Bakris, Geoffrey A Block, et al.
Pageof 21